No serious side effects were reported in this study.
The table below shows the number of patients (percent) with non-serious side effects
that were reported by two percent or more patients in this study.
Number of patients (percent) with non-serious side effects that were
reported by two percent or more patients
TDF
213 patients
Higher than normal levels of a liver protein in the blood 6 (3%)
Lower than normal levels of phosphate in the blood 5 (2%)
How has this study helped patients and researchers?
This study showed that majority of the patients with chronic hepatitis B, who did not
respond well to treatment with multiple NAs previously, responded to treatment with
TDF. The side effects reported in this study were limited and non-serious.
Are there plans for further studies?
Other studies on TDF in patients with chronic hepatitis B have been conducted and
more are underway.
Where can I find more information about this study?
Clinical studies have unique study numbers that are included in publications and other
information about the study. The unique study number associated with this study is
shown below with an internet link to the scientific summary and other information.